MYDRIN-P Santen eye drops relax pupils (10ml)

Dosage form Bottle x 10ml
Specifications Tropicamid, phenylephrine hydrochloride

Ingredient

Composition information	Content
Tropicamid	0.5%
Phenylephrine hydrochloride	0.5%

Uses

indications

Mydrin-P 10 ml drug is indicated in the following cases:

dilate the pupils and paralysis of the body for the purpose of diagnosis or treatment.

When small eye solutions contain tropicamid and phenylephrin hydrochloride at different concentrations into the eyes of albino rabbits, pupils dilate by tropicamid causing dilatation of pupils and phenylephrin hydrochloride causing muscle stretching muscles. The enhanced pupil relaxation effect in Tropicamid - Phenylephrin 1: 1 combination ratio due to the synergistic effect of both of these components.

Effects of body paralysis

This product is 1-2 times into the eyes of a child with vision or clear reduction to measure refractive and compare the paralysis effect of this product with atropine 0.5% or 1% after 3 times/day for 3 days. This product has a weaker paralysis of the mi body than atropine.

Dynamic pharmacokinetics

onset of effect

A drop of a small eye solution containing tropicamid 0.5% and phenylephrin hydrochloride 0.5% 3 times 3 minutes apart into one eye of a healthy volunteer (n = 8 from 23 - 33 years old) and no other eye treatment. The nearest viewing distance and the diameter of the pupils are measured after treatment. Maximum maximum maximum pupils and paralysis effects are achieved after 15-20 minutes and 20 - 30 minutes respectively.

Effect time

A drop of small eye solution containing tropicamid 0.5% and phenylephrin hydrochloride 0.5% 3 times 3 minutes apart and add 3 more times to 20 minutes into one eye of a healthy volunteer (n = 8 from 23 - 33 years old) and no other eye treatment. The mi body paralysis effect has been created in 5-6 hours after the last small drug.

Before taking MYDRIN-P Santen eye drops relax pupils (10ml)

How to use

myrin-P 10 ml is eye drops.

Dosage

to relax the pupils usually 1-2 drops/time or 1 drop/time x 2 times 3-5 minutes apart.

To paralyze the body, usually 1 drop/time x 2-3 times 3 - 5 minutes apart.

The dosage can be adjusted according to the patient's symptoms.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?

Expression:

Flush, dry skin, blurred vision, fast and irregular circuit, fever, abdominal distention in children, convulsions, hallucinations, loss of neuromuscular coordination.

Management:

Support treatment. In children should apply damp towels. If the wrong drink must cause vomiting or gastric lavage.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using myrin-P 10 ml, you may experience unwanted effects (ADR).

Shocking, anaphylactic reaction (unknown incidence): Patients should be carefully monitored because of the shock and anaphylactic reaction that may occur. If observations see any symptoms such as erythema, rash, shortness of breath, lower blood pressure, eyelid edema, etc. should stop taking the drug and apply appropriate treatment measures.

Unknown frequency

Hypersensitivity: eyelash infection (red eyelid, swelling of the eyelids, eyelid dermatitis, itching, rash).

eyes: conjunctivitis (conjunctivitis, conjunctiva, eye rust, etc.). Corneal epithelium disorders, increased internal pressure.

stomach - intestines: thirst, nausea, vomiting.

Other: flushing, tachycardia, hypertension, headache, urticaria.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

MYDRIN-P 10 mL contraindications in the following cases:

Patients with glaucoma or patients who are likely to be glaucoma due to narrow angle or shallow room. (May occur acute angle glaucoma.)

Patients with a history of hypersensitivity to any component of the drug.

Caution when using

Use cautiously (cautious when taking this medication for the following patients)

Children. 1 of phenylephrin).

Special prudence

Because the heart rate is slow, apnea, etc., this drug is used for young babies to look at the bottom of the eyes, so it is necessary to be careful when using this medication and closely monitor the patient's condition.

Do not use this drug in the event of a discoloration or precipitation.

The ability to drive and operate machinery

Because this drug relaxes the pupil and/or paralysis of the body, the patient should be cautious when participating in activities that are likely to be dangerous, such as operating machinery or driving. Instruct patients to protect eyes to avoid direct sunlight or other strong light by wearing sunglasses or in other ways.

Pregnancy

The safety of this drug in pregnant women has not been set. In general, the pupils should only be used for pregnant women if the treatment is assessed as necessary.

The period of breastfeeding

The safety of this drug in breastfeeding women has not been established. In general, the pupils should only be used for breastfeeding women if the treatment is considered to be necessary. Must stop breastfeeding during treatment.

Interactive drug

Drugs

Signs, symptoms and treatment

Mechanisms and risk factors

round 3 week after treatment).

rapid increase in blood pressure.

Inhibitors

Mao can inhibit

Transfer enzymes

Chemistry of this drug, and

can increase the

sensitive to catecholamine.

3 -round depression

or 4 rounds

maprotilin hydrochloride

Clomipramin hydrochloride amoxapin.

rapid increase in blood pressure.

These drugs may be

Inhibition of absorption

norepinephrin at the beginning

Neuroscope

sympathetic, and maybe

Increases the concentration

Epinephrin in receptors.

Storage

Store less than 30 ° C in closed packaging.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.